News and updates institute for child health policy
The ICHP Newsroom is the hub for faculty news and research, including press releases, upcoming events, announcements and media coverage.
News
Research on monitoring blood pressure to minimize…
A new five-year study of chronic kidney disease in children will draw on University of Florida informatics expertise to investigate how medication…
Fellows in pediatric cancer to benefit from…
A successful communication skills training program about clinical trials is expanding to cover pediatric cancer. The workshop trains medical oncology…
Shenkman honored as UF Distinguished Professor
Dr. Elizabeth “Betsy” Shenkman, Ph.D., has earned the highest honor for a faculty member at the University of Florida: Distinguished Professor…
Grand Rounds
Advancing Black Maternal Healthcare
On March 20, 2024, Katilya Ware, PhD, RN, from Auburn University, gave a Grand Rounds presentation on “Bridging Gaps and Transforming Outcomes: Advancing Black Maternal Healthcare.”
HPV research
Cancer Research Showcase 2025
Student Sara Tohme shared a winning poster in the category for Predoctoral Students. The poster summarized research on educating vulnerable women on self-testing for the human papillomavirus (HPV).
Texas External Quality Review Organization
Three employees win Superior Accomplishment
Congratulations to three HOBI employees who received 2022-2023 Superior Accomplishment Awards for excellent work performance at the division level.
Employee & Student
Congratulations to doctoral graduate Sarah Chavez
Chavez worked full time as a research coordinator III for the Institute for Child Health Policy (ICHP) External Quality Review Organization (EQRO) project.
march 6, 2021
Straight talk about vaping for parents
Award
Grant to help UF Health researchers boost HPV vaccinations among youngsters
A team of UF Health researchers has received a five-year, $2.9 million grant from the National Cancer Institute to evaluate simple interventions aimed at health care providers and parents that could substantially boost vaccine rates for human papillomavirus, or HPV, among 11- and 12-year-olds.